Jeremy R. Chapman; Stephen J. Wigmore
The outcome of SARS-CoV-2 vaccination in vulnerable populations has been a cause for especial concern among transplant patients and the medical teams responsible for advising them. The prospect that immunosuppressed patients would not respond to vaccines for COVID prevention was based on the known need to specifically tailor vaccines for this population, for example, Shingles.

Read More

Chris J. Callaghan; Lisa Mumford; Rebecca M.K. Curtis; Sarah V. Williams; Heather Whitaker; Nick Andrews; Jamie Lopez Bernal; Ines Ushiro-Lumb; Gavin J. Pettigrew; Douglas Thorburn; R. Forsythe; Romme Ravanan on behalf of the NHSBT Organ and Tissue Donation and Transplantation Clinical Team
The clinical effectiveness of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in immunosuppressed solid organ and islet transplant (SOT) recipients is unclear.

Read More